|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:tamoxifen
|
|
gptkbp:approvalYear
|
2006
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:L02BA01
|
|
gptkbp:brand
|
gptkb:tamoxifen_citrate
|
|
gptkbp:contraindication
|
pregnancy
history of deep vein thrombosis
history of pulmonary embolism
|
|
gptkbp:drugClass
|
antineoplastic agent
hormonal antineoplastic agent
|
|
gptkbp:form
|
oral solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Soltamox
|
|
gptkbp:indication
|
treatment of metastatic breast cancer
reduction of breast cancer incidence in high-risk women
adjuvant treatment of breast cancer
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:DARA_BioSciences
|
|
gptkbp:mechanismOfAction
|
selective estrogen receptor modulator
|
|
gptkbp:pregnancyCategory
|
D
|
|
gptkbp:prescriptionStatus
|
Rx only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:endometrial_cancer
nausea
fatigue
hot flashes
thromboembolism
|
|
gptkbp:usedFor
|
gptkb:cancer
gptkb:ductal_carcinoma_in_situ
metastatic breast cancer
breast cancer risk reduction
|
|
gptkbp:bfsParent
|
gptkb:tamoxifen
|
|
gptkbp:bfsLayer
|
6
|